Ocean Biomedical, Inc.
(NASDAQ:OCEA)
$0.82
0.03 (4.04%)
At Close: 4:00 PM
OCEA Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
OCEA Stock Price Today
Ocean Biomedical, Inc. (OCEA) stock declined over -5.24% intraday to trade at $0.8244 a share on NASDAQ. The stock opened with a gain of 121.52% at $1.75 and touched an intraday high of $1.77, rising 4.35% against the last close of $0.79. The Ocean Biomedical, Inc. in stock market went to a low of $1.67 during the session.
OCEA Stock Snapshot
$0.79
Prev. Close
28.04 Million
Market Cap
$1.67
Day Low
$1.75
Open
10.6 Million
Number of Shares
$1.77
Day High
N/A
P/E ratio
-3.25
EPS (TTM)
0.03
Cash Flow per Share
N/A
Free Float in %
-0.25
Book Value
256554.00
Volume
OCEA Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Room 325, 55 Claverick StreetProvidence, RI US
Website:http://www.oceanbiomedical.com
Contact #:401-444-7375
Company Information
Employees9.00
Beta-0.28
Sales or RevenueN/A
5Y Sales Change0.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP, as well as a product candidate for the treatment of COVID-19 in hospitalized patients. The company was incorporated in 2019 and is based in Providence, Rhode Island.
Peers
Frequently Asked Questions
What is the current Ocean Biomedical, Inc. (OCEA) stock price?
Ocean Biomedical, Inc. (NASDAQ: OCEA) stock price is $0.82 in the last trading session. During the trading session, OCEA stock reached the peak price of $1.77 while $1.67 was the lowest point it dropped to. The percentage change in OCEA stock occurred in the recent session was -5.24% while the dollar amount for the price change in OCEA stock was -$0.05.
OCEA's industry and sector of operation?
The NASDAQ listed OCEA is part of Biotechnology industry that operates in the broader Healthcare sector. Ocean Biomedical, Inc. , a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation.
Who are the executives of OCEA?
Ms. Elizabeth Ng M.B.A.
Chief Executive Officer & Director
Mr. Gurinder Singh Kalra M.B.A.
Chief Financial Officer
Mr. Daniel Behr M.B.A.
Executive Vice President & Head of External Innovation and Academic Partnerships
Dr. Chirinjeev Baboo Kathuria M.B.A., M.D.
Founder & Executive Chairman
How OCEA did perform over past 52-week?
OCEA's closing price is 1.06% higher than its 52-week low of $1.67 where as its distance from 52-week high of $26.599 is -0.76%.
How many employees does OCEA have?
Number of OCEA employees currently stands at 9.00. OCEA operates from Room 325, 55 Claverick Street, Providence, RI , US.
Link for OCEA official website?
Official Website of OCEA is: http://www.oceanbiomedical.com
How do I contact OCEA?
OCEA could be contacted at phone #401-444-7375 and can also be accessed through its website. OCEA operates from Room 325, 55 Claverick Street, Providence, RI , US.
How many shares of OCEA are traded daily?
OCEA stock volume for the day was 256554.00 shares. The average number of OCEA shares traded daily for last 3 months was 229.36 Thousands.
What is the market cap of OCEA currently?
The market value of OCEA currently stands at $28.04 Million with its latest stock price at $0.82 and 10.6 Million of its shares outstanding.